Accendra Health, Inc.

ACCH · Industrials · FY2025 filings · · No moat ·

Doesn't clear the bar

No moat
Share / Embed this score
Embed this score

The five investor questions

15

2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $9.8B to $2.8B, decreasing; diluted EPS 2.94 to -14.31, decreasing.

0

Median gross margin 15.3% over 10y, variable.

4

Median ROIC 3.6%, above the 12% hurdle in 10% of years.

0

Net debt/EBITDA 7.3x, interest coverage 0x.

24

Owner earnings changed trend unclear over up to the ten most recent annual observations.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
No price data
Not reported
Unavailable — insufficient owner-earnings data
Unavailable — insufficient growth-model data
Unavailable — no recent price
No price data

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.

Among the current top-score group, the median current price is 260% above the zero-growth estimate across 49 of the current top 50 companies by Moat Score with both values.

Score records captured Nov 19, 2026.

Exactly which 50 companies?

FTNT, IBEX, META, MEDP, MSFT, GOOG, LULU, ANF, IDXX, TXRH, FHI, QLYS, ADBE, LLY, MANH, CPRT, VEEV, RMD, GRMN, FFIV, PCTY, EAT, UI, SSD, MNST, DOCS, LRCX, MCO, NTAP, NVDA, CORT, SFM, MPTI, ULTA, SN, ROL, CTAS, PAYC, IRMD, DECK, MORN, INTU, JKHY, TPR, LGCY, UCFI, DAL, GWW, ISRG, MPWR

Missing a usable price or zero-growth estimate: ANF.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

19 years of fundamentals

The business, in plain English

Accendra Health, Inc. booked $2.8B of revenue in FY2025 in the Industrials sector and kept 46.7% of it as gross profit — a solid-margin business by that measure. After every other cost, −39.8% of each revenue dollar reached the bottom line.

Across the filed record, revenue shrank from $7.2B (FY2008) to $2.8B (FY2025) — about −5.5% a year compounded over 17 years.

It earned 1.7% on invested capital in the latest filed year, FY2025. Across the full 18-year measurable filed record, median ROIC was 9.5%. Over the v3 recent window (10 measurable filed years), median ROIC was 3.6%. The Returns on Capital filter above scores it 4/100.

The balance sheet carried $2.0B of total debt in FY2025. Balance-Sheet Safety scores it 0/100.

Put together: Capital Allocation is the strongest of the five filters (24/100) and Balance-Sheet Safety the weakest (0/100), which is how ACCH lands at 9/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2007–FY2025 · 19 fiscal years, normalized from ACCH’s SEC filings

Sales, as filed$2.8B FY2025
$0$5B$10B2007201320192025
Revenue kept after cost of goods46.7% FY2025
0%50%2007201320192025
Standard ROIC or separately labeled Operating ROICStandard ROIC 1.5% FY2025

Exact FY and FY-1 financing invested-capital inputs are required.

0%2007201320192025
Cash an owner could take out−$1.1B FY2025
−$1B$02007201320192025

The explained ROIC gaps have filed inputs but no meaningful positive invested-capital denominator. Other gaps mean the item is not in the filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How Accendra Health, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$2.8B · 100%Cost of revenue$1.5B · 53%Gross profit$1.3B · 47%Operating income$27.5M · 1%Income before tax−$102M · −4%Income tax$729000 · 0%Net income−$1.1B · −40%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$2.8B100%
Cost of revenue$1.5B53%
$1.3B47%
$27.5M1%
Income before tax−$102M−4%
Income tax$7290000%
−$1.1B−40%
Source: · event Dec 31, 2025 · retrieved Nov 19, 2026 · annual-row source set
Embed this chart

Flagship explainer

What Accendra Health, Inc. owns — and owes

Accendra Health, Inc.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$2.5B100%
Cash and equivalents$282M12%
$2.0B84%
Stockholders’ equity−$461M−19%
Source: · event Dec 31, 2025 · retrieved Nov 19, 2026 · annual-row source set

Flagship explainer

What drives Accendra Health, Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−1756%Tax burden1080%net income ÷ pretax incomeInterest burden−371%pretax ÷ operating incomeOperating margin1%operating income ÷ revenueAsset turnover0.78×revenue ÷ average assetsEquity multiplier56.69×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$1.1BFY2025
Income before tax−$102MFY2025
Operating income$27.5MFY2025
$2.8BFY2025
Ending assets$2.5BFY2025
Beginning assets$4.7BFY2024
−$461MFY2025
$586MFY2024
Source: · event Dec 31, 2025 · retrieved Nov 19, 2026 · annual-row source set
Embed this chart

Flagship explainer

Where Accendra Health, Inc.'s cash went

Accendra Health, Inc.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations−$102M−100%
Depreciation and amortization$215M211%
Source: · event Dec 31, 2025 · retrieved Nov 19, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding Accendra Health, Inc.

Delayed public 13F reports for 2026-Q3—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 not retrieved

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Abrams CapitalNot retrievedComparison not retrievedFiling not retrieved
Akre CapitalNot retrievedComparison not retrievedFiling not retrieved
Baupost GroupNot retrievedComparison not retrievedFiling not retrieved
Berkshire HathawayNot retrievedComparison not retrievedFiling not retrieved
Brave Warrior AdvisorsNot retrievedComparison not retrievedFiling not retrieved
Dodge & CoxNot retrievedComparison not retrievedFiling not retrieved
First EagleNot retrievedComparison not retrievedFiling not retrieved
FundsmithNot retrievedComparison not retrievedFiling not retrieved
Gardner Russo & QuinnNot retrievedComparison not retrievedFiling not retrieved
Gates Foundation TrustNot retrievedComparison not retrievedFiling not retrieved
Mairs & PowerNot retrievedComparison not retrievedFiling not retrieved
Markel / Markel-GaynerNot retrievedComparison not retrievedFiling not retrieved
Oakmark / Harris AssociatesNot retrievedComparison not retrievedFiling not retrieved
Pershing SquareNot retrievedComparison not retrievedFiling not retrieved
Polen CapitalNot retrievedComparison not retrievedFiling not retrieved
Sequoia / Ruane CunniffNot retrievedComparison not retrievedFiling not retrieved
Southeastern Asset ManagementNot retrievedComparison not retrievedFiling not retrieved
Tweedy, BrowneNot retrievedComparison not retrievedFiling not retrieved
Yacktman Asset ManagementNot retrievedComparison not retrievedFiling not retrieved

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source not retrieved · event Sep 30, 2026 · retrieved Nov 19, 2026

Flagship explainer

What Accendra Health, Inc. insiders reported

Records still being gathered — partial as of retrieval Nov 19, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

1 logged reading since Nov 19, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale8.6 / 100
0406080100WideNarrowShallowNo moatNov 19, 2026

Score history begins Nov 19, 2026 — the record builds forward from here.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

None yet — ACCH has read No moat for every logged capture since Nov 19, 2026.

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Nov 19, 2026.

Among the rows shown, A/F/M acquisition, payment or withholding, and exercise or conversion rows outnumber S sale rows (2 versus 1). The filing codes alone do not establish that every such row arose from a compensation plan.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

InsiderShares owned afterDateFiling detail
Bernocchi Perry Aformer Chief Operating OfficerOpen-market or private sale (S)Table I · Disposed · Common Stock33,161$0.122$4,046280,752Nov 16, 2026
1 filed lot
  • Table I · Common Stock: 33,161 shares at $0.122 · code S · owned after 280,752 ·
Gardner-Smith KennethDirector, President & CEOGrant, award, or other acquisition (A)Table I · Acquired · Common Stock283,554—Grant, award, or other acquisition (A)—369,667Oct 5, 2026
1 filed lot
  • Table I · Common Stock: 283,554 shares at — (Grant, award, or other acquisition (A)) · code A · owned after 369,667 ·
Leon Jonathan AEVP & CFOPayment of exercise price or tax liability (F)Table I · Disposed · Common Stock4,265$0.85$3,625286,268Sep 23, 2026
1 filed lot
  • Table I · Common Stock: 4,265 shares at $0.85 · code F · owned after 286,268 ·

Source-event as of . Retrieved .

Industrials context

#450 of 450 scored Industrials companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #448AQMS Aqua Metals, Inc.12.9 out of 100, No moatNo moat
  2. #449HYFM HYDROFARM HOLDINGS GROUP, INC.12.8 out of 100, No moatNo moat

Compare ACCH with its nearest peers →All Industrials companies on the Index →

Common questions about ACCH

Does Accendra Health, Inc. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores Accendra Health, Inc. (ACCH) 8.6 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 15, pricing power 0, returns on capital 4, balance-sheet safety 0, capital allocation 24.
How has ACCH's Moat Score changed over time?
The record logs 1 reading since Nov 19, 2026; the latest reads 8.6 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.